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Introduction The complex healthcare system that provides patients with medicines places them at risk when care is transferred between healthcare organisations, for example discharge from hospital. Consequently, understanding and improving medicines management, particularly at care transfers, is a priority.
Objectives
This study aimed to explore the medicines management system as patients experience it and determine differences in the patient-perceived importance of people in the system.
Methods
We used a Social Network Analysis framework, collecting ego-net data about the importance of people patients had contact with concerning their medicines after hospital discharge.
Single-and multi-level logistic regression models of patients' networks were constructed, and model residuals were explored at the patient level. This enabled us to identify patients' ego-nets with support tie patterns different from the general patterns suggested by the model results. Qualitative data for those patients were then analysed to understand their differing experiences.
Results
Ego-nets comprised clinical and administrative healthcare staff and friends and family members. Ego-nets were highly individual and the perceived importance of alters varied both within and between patients. Ties to spouses were significantly more likely to be rated as highly important and ties to community pharmacy staff (other than pharmacists) and to GP receptionists were less likely to be highly rated. Patients with low-value medicines management networks described having limited information about their medicines and a lack of understanding or help. Patients with high-value networks described appreciating support and having confidence in staff.
Conclusions
Patients experience medicines management as individual systems within which they interacted with healthcare staff and informal support to manage their treatment. Multilevel models indicated that there are unexplained variables impacting on patients' assessments of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59
Introduction
The healthcare system that provides patients with their medicines can also place them at risk, especially when their care is transferred between healthcare providers, for example, at hospital discharge. 1 Among the risks to patient safety in the transfer of care are poor communication between care providers about changes to prescribed medicines during the hospital admission, 2 3 the insufficient provision of information to patients about their medicines when they leave hospital, 4 and deficits in the quality of medicines reconciliation. 5 Medicines management is the UK healthcare system that supports the prescribing, dispensing, monitoring, reviewing and use of medicines. [6] [7] [8] It is a multi-professional, sociotechnical system within which patients interact with different healthcare professionals. 9 These professionals often work from different sites and settings such as hospitals, GP practices, specialist clinics and community pharmacies, and use different technical systems to support care. People in the system may operate independently yet concurrently and the system can be unpredictable. For example, patient responses to changes to medicines may not be as expected and one organisation may not respond to instructions or communications made by another, for example not implementing recommendations for changed medicines by specialists. In this way the medicines management system can be considered a complex adaptive system. Complex adaptive systems thinking recognises complexity, accepting that linear 'cause and effect' models of healthcare are too simple and do not take into account the decentralised structure of care and dispersed system controls. 10 System performance or behaviours in complex adaptive systems are unpredictable, networks of 'agents' in the system react to the actions of others and connections between agents in the system are critical to success or survival. 11 Fraser and Greenhalgh (2001) described several properties of complex adaptive systems, which we have considered in the context of medicines management and presented in Table   1.   60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  Table 1 
: Examples of the features of complex adaptive systems applied to medicines management adapted from Fraser and Greenhalgh 2001 12

Features of complex adaptive systems
Examples in medicines management
The system and its external environment are not constant People -such as clinicians or spouses -in the system change depending on patients' access to services and informal support, health condition, and co-morbidities. The environment in which medicines are taken also varies. Individuals in the system are independent and creative decision makers Each patient and clinician makes decisions about which medicines are prescribed and taken, how they are titrated, how they are monitored and how they are managed in the home. Uncertainty and paradox are inherent Patient responses to treatment vary and treatment for one condition may impact on another condition. Problems cannot always be solved but they can be improved Many chronic conditions cannot be cured, only managed with medicines.
The inherent risks in the transfer of care can be reduced but not eliminated. Effective solutions can emerge from minimum specification A small improvement to document the reason why a medicine has changed is not difficult to achieve yet it can substantially improve safety. Small changes can have big effects Changes made to treat one health condition may have adverse impacts on patients' co-morbidities. Actions taken or not taken by one person in the system can cause a safety incident which can manifest in a different part of the system. Behaviour exhibits patterns (can be termed 'attractors')
Patients order medicines through their GP practices and would normally have them dispensed in the same community pharmacy.
GP practices would usually have a process for processing discharge summaries.
Patients may have an established routine or process for managing their medicines. Change is more easily adopted when in taps into these patterns Co-design with exiting patients of self-management routines would tap into their existing management patterns.
In the UK, the National Health Service (NHS) aspires to healthcare that is person-centred, 13 taking into account their individual needs and preferences. Medicines management is characterised by a focus on personal interactions, 14 and as care recipients, patients have a view of care interactions that may not be afforded to others in the system. However, many patients' experiences of navigating this system are less than optimal: they can be confused by the information they have (or have not) been given about their medicines, 4 15 and they spend time actively monitoring for errors made by healthcare professionals. 16 17 119  120  121  122  123  124  125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177   4 Patients are usually discharged from the hospital in the UK with a supply of medicines of up to 4 weeks and information about the patient's new list of medicines is sent to their primary care practice. Information is not routinely sent to community pharmacy unless the patient uses a multi-compartment compliance aid. Their next prescription will be issued by their GP and either sent to their community pharmacist or collected by the patient and taken to the community pharmacy to be dispensed. Many cardiology patients are referred by the hospital to cardiac rehabilitation and heart failure nursing services, which provide care for a specified period. Waiting times for these services are increasing nationally and the number of patients with co-morbidities that access them is also increasing. 18 Given the evident complexity in the medicines management system and the impact this has on patients, this study aimed to explore and appraise the composition of the medicines management system from the patient viewpoint to understand how this healthcare system operated after hospital discharge and the range of different healthcare professionals who comprise the system that patients must navigate. Viewing healthcare systems as social networks allows the type and value of care and support patients receive from healthcare professionals and patients' own informal contacts to be considered. Consequently, a Social Network Analysis (SNA) framework was judged to be the most suitable methodology.
The overall objectives of the study were to: 1
Describe the medicines management system from the patient perspective.
2
Understand which professional and personal ties, such as community pharmacy, GPs and administrative staff, perform important functions for patients.
Theoretical model
We characterised the medicines management system as a personal network (an ego-net), in which the patients were the 'egos' and the people they interacted with concerning their following their discharge were their network members. The ties between patients and network members were patient assessments of the importance of that person to them in managing their medicines, and these ties were the units of analysis.
Ego-net analysis of medicines management
There are few published studies using ego-net or personal network approaches to explore HCPs and informal network members, such as their family and friends, some of whom had healthcare experience. 19 A further study used an ego-net approach to explore roles in 17 The authors used the concept of 'medicines work' to explore the roles of others in enabling medicines taking. They found that personal network members performed tasks such as collecting and monitoring medicines, offering emotional support, and providing information to patients.
Methods
Study setting and recruitment
We collected data about the people cardiology patients had contact with relating to their medicines via diaries and face-to-face semi-structured interviews during a six-week period following their discharge from two hospitals in the North of England. Site 1 was a 900-bed hospital forming part of an NHS teaching hospital foundation trust serving a population of approximately 0.5 million people in 100,000 households. According to Public Health England, over a quarter of adults in the areas were classified as obese and smoking related deaths were worse than the English average. Early deaths (people under 75 years of age) from heart disease and stroke had been consistently higher than the English average. Eligible patients were approached on the day of discharge by one experienced healthcare researcher (BF) who explained the study to them, gave them the patient information leaflet, which they were given time to read and to discuss with friends or family if they wished to do so. Patients who were willing to take part completed and signed a consent form. The researcher explained to the patient how to keep the diary records and agreed that the patient would be contacted by telephone after few days to see how they were managing their diaries and to arrange set-up of the subsequent interview. NHS Research Ethics Committee approval was obtained (13/NI/0118). 237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295 6
Data collection
Data were collected between November 2013 and June 2014. During the six weeks following their discharge, patients were asked to keep paper diary records of the people they had had contact with concerning their medicines. They were asked to record each day in their diaries the contacts that had been made, the role of the person or relationship to them.
There was space in the diary for the purpose and the mode (e.g. telephone) of the contact to be noted. We did not predefine who they should include, however patients were given examples of the types of contact they might record, for example GPs, nurses, pharmacists, friends and family. They were also given example diary records as shown in Table 2 and
given the researcher's contact details to use if they had queries. Diaries were used as prompts during semi-structured interviews held approximately six weeks following discharge from hospital. The interview schedule was constructed so that contact data could be collected during interviews if patients did not wish to keep a diary or did not feel able to do so. The semi-structured interview schedule comprised questions, probes and prompts exploring patients' experiences with their medicines since leaving the hospital and the contact they had had with healthcare professionals and others concerning their medicines. During interviews a hierarchical personal network tool was used to collect data about patients' medicines networks following previously applied methods. 20 296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354   7 positioned based on how important the patient thought that person was to managing their medicines. A ranking of 1 was the most important and 4 the least important so the closer they placed them to the middle of the diagram, the more important the patient perceived that person to be. Patients were asked 'How would you rate the contacts involved in your medicines?' 'Why do these people play a bigger role than others in your medicines?', 'Why are these people not so important?' and 'How much do you feel each of these people listen to you? And understand you?' The names and positions of patients' medicines contacts formed their ego-nets for quantitative analysis. An example of the tool used is shown in Figure 1 . Tie values were then dichotomised: for each network member the highest value was recorded as '1' values of '1-3' were recorded as '0'.
Data were analysed in SPSS v.22 using descriptive statistics to explore the composition of patients' networks and the importance of the types of network members. Data were then analysed using inferential statistics to explore the variation in importance for different network member types and whether network ties varied from patient to patient as well as by type of tie. This was also done to give insight into whether experiences of medicines management were different for each patient regardless of their network composition. A single-level logistic regression model was fitted in the statistical programme R 23 linked to MLWIN v 2.35. [24] [25] [26] The outcome variable was the dichotomised importance value.
Explanatory variables were the site, the patient's age, the patient's gender, and the role or relationship of the network member. The reference category for patient gender was male, site was Site 1 and the reference category for network member type was the GP. A multilevel version of the models was then fitted adding a patient level to the data to explore the extent of the tie value variation between patients. These allowed inference about whether the perceived importance of network ties varied from patient to patient as well as by type.
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The dependent variable is whether the network member is highly important to the patient, therefore π ij is the probability that the tie between the network member i and patient j is of high importance. X′ ij β model fixed effects that may be characteristics of the patient (e.g. age or gender) or the network member (e.g. professional role). u j is a normally distributed random effect for the intercept of the regression model at the patient level (Level 2), where . Level 1 variation between network members of the same patient (with the
Following previous applications of this method, 27 28 we have assumed no overlap between networks; no member of one patient's network was assumed to be a member of another patient's network. Model estimation was achieved via a Markov Chain Monte Carlo method (MCMC), and the goodness of fit of the various models was compared using the Bayesian Deviance Information Criterion (DIC). The residuals of the best fitting model were analysed and extreme cases, not following the typical patterns of ties expected by the model, were explored qualitatively to understand more about their post-discharge experiences. This sequential mixed methods analysis combining interview data with quantitative network analysis allowed in-depth interpretation of the networks data and offered contextual information to the network strucutres. 29 Results 75 patients were recruited to the study; 15 were lost to follow-up because: the study team could not contact them (3), they did not wish to take part (3), they were ill (7) , and two patients died. 60 patients were retained in the study, 39 of whom kept diary records and 60 took part in interviews. One patient was interviewed 12 weeks following discharge because he had been readmitted for surgery. Patients' ages ranged from 35-80 (m 62; SD 10.3), 42
were male and 18 were female.
Descriptive analysis
In total, 60 patients reported 383 medicines contacts with a mean network size of 6.47 414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472   9 least one healthcare professional or support staff member. In total, 60 patients had 273 such contacts. GPs (n=56) were the most commonly reported healthcare professional type, although a quarter of the sample had no direct GP contact. There were 53 nurses (other than specialist cardiology nurses) who were GP practice-based, clinic-based, and also hospital-based. Just over half of patients (43) recounted contact with community pharmacists. Cardiac rehabilitation nurses or heart failure nurses were present in the networks of 35 patients. Informal contacts included spouses (8% of all network members) and other family members and friends (20%) such as children, parents and siblings, friends and neighbours. Relatives, such as in-laws and cousins, also featured along with other people patients knew but were not close to, for example acquaintances at church. Some of these informal contacts had healthcare experience, e.g. they were GPs, current and former nurses, and healthcare assistants.
Patients attributed the highest importance to over two fifths of their network members (44%) and spouses commonly attracted the highest ratings. GP receptionists attracted the most negative assessments by patients with nearly half being placed in the lowest value category by patients. Table 2 shows the number of people in each category and the importance placed on them by patients. 
Single-level model of the network ties
Model 1 in Table 3 was a single-level logistic regression of the likelihood of a network member being highly important to the patient -fitted mainly as a baseline model to be compared for goodness of fit with the more realistically complex multi-level model. 473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531   10 Compared with GPs, all healthcare staff network members were less likely to be highly important members of patients' networks. Patients' spouses were significantly more likely to be highly important network members (p=<0.05 (CI 0.03 -1.971)). Increase in age was also significantly more likely to positively impact on network ratings (p=<0.01(CI 0.008 -0.0516)).
GP reception staff (p=<0.01(CI -3.658 --0.813) and community pharmacy staff (not pharmacists) (p=<0.01(CI -2.755 --0.589)) were significantly less likely to be highly rated.
Multi-level model of the network ties
Multi-level models better represent these patient networks and allow the nature and extent of variation in ties between and within patient networks. Model 2 in Table 4 is a multi-level logistic regression of the likelihood of a tie being highly rated by the patient. It has a reduced DIC of 495.29, indicating that controlling for patient-level variation improves the statistical model fit. In this model, increasing age still significantly increases the likelihood that network ties will be highly important to patients (p<0.05 (CI 0.003 -0.065). Spouses are also still significantly more likely than GPs to be highly important network members (p<0.05 (CI 0.112 -2.218)) and the likelihood of ties to community pharmacy staff (p=0.001 (CI -3.247 --0.827)) and to GP receptionists (p<0.01 (CI -4.147 --1.032)) being highly rated is reduced compared to GPs. 532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590 11 staff 
Analysis of the model residuals
We analysed the residuals for the best fitting model (Model 2) to see, having controlled for the explanatory variables in the model, which patients valued their networks on average more highly than others and which patients attributed lower values on average (extreme cases). A caterpillar plot of the residuals for Model 2 is in Figure 2 and the extreme residuals are presented in Tables 4 and 5 for the tail and head of the residuals plot. We then explored the composition of those networks and the patients' experiences of managing their medicines. Cases with extreme residuals indicated the patients for whom tie variation cannot 12 be explained well by the model and further qualitative assessment of these cases was carried out. other friends or family support with medicines and felt that little information had been given to her in the hospital about newly prescribed medicines. Overall, this patient described being frustrated with the levels of medicines-related care she had experienced. She described feeling "like I'm 50%, I'm not 100%". She had been given incorrect information by the hospital about discontinuing a medicine in advance of a test, which had annoyed her, and described having low levels of confidence in the efficacy of her medicines and that her health conditions and response to her medicines were not being effectively managed.
"I believe that they [health professionals] should think, 'well she's still got the hypertension, which I'll have but it's ridiculously high, she's maxed out on all of her blood pressure tablets and the majority of the angina medication, she's already had a heart attack, the angina is more prevalent than it was before the heart attack, we should really be getting her sorted out.'" (Patient 18)
Patient 13 had a large medicines management network with six friends and family members and a range of staff from different healthcare organisations providing medicines management functions for the patient's cardiology conditions and other co-morbidities. He did consider some of his healthcare professionals, such as his GP, to be important; however none of his informal network, including his spouse, was highly valued. This patient ordered 13 his medicines himself using the GP practice's online system and checked for himself the list of available medicines against the hospital discharge note. He attributed the highest value to his GP and hospital cardiologist and perceived much less value in the rest of his care team.
In particular his usual community pharmacist was given the lowest value because he appraised their function and availability to be limited.
"Well, I don't always see the chemist when I go… I may be wrong, but they can't change [the medicines], they have to go through a GP, or a consultant anyhow." (Patient 13)
Patient 50 described discontinuing two of her medicines during the immediate postdischarge period because she didn't understand why she needed to take them. She had asked for help from her spouse in organising her supplies but this had not been forthcoming.
She also felt that healthcare staff had not taken into account her preferences, for example not wishing to take statins. She described perceiving the need to be given more explanation about the function of medicines and the reason for needing to take them. 709  710  711  712  713  714  715  716  717  718  719  720  721  722  723  724  725  726  727  728  729  730  731  732  733  734  735  736  737  738  739  740  741  742  743  744  745  746  747  748  749  750  751  752  753  754  755  756  757  758  759  760  761  762  763  764  765  766  767   14 leaving the hospital and explained that the services of her community pharmacist and pharmacy delivery driver were important and she valued them for their reliability and the convenience of having medicines delivered.
"He [the pharmacy delivery driver] delivers them, doesn't he? Without him I'd have to go find them myself, wouldn't I?" (Patient 47)
Patient 48 had a network of seven people, six of whom were healthcare staff. She described her daughter as acting as her advocate with the healthcare team. She had experienced sideeffects whilst taking a beta-blocker but her GP had taken action and she described not needing to talk with anyone about here medicines because "I just take them and get on with it". Nevertheless she felt confident that her GP, other practice staff and staff at her community pharmacy were approachable if she had problems with her medicines. He placed importance on a pacemaker technician who advised him to take the prescribed dose of beta-blocker after the patient had told him he had decided to take half the dose. He felt he had a good relationship with his GP, however, he was critical of the GP practice receptionist staff who he thought provided poor service and his new medicines had also been missing from his repeat prescription. This patient, however, praised the staff at his community pharmacy for their helpfulness.
"They [community pharmacy staff] are brilliant, they are really good, they are and extremely helpful, they make you feel that you need... that you know they are there to help you."
(Patient 54)
Discussion
We found that patients discharged from cardiology wards have individual medicines management networks with different compositions and different sizes that included clinical and non-clinical staff and friends and family members. Over two fifths of the people in patients' networks were perceived to be highly important in managing medicines. We also found that not all patients had contact with GPs and community pharmacists following their 768  769  770  771  772  773  774  775  776  777  778  779  780  781  782  783  784  785  786  787  788  789  790  791  792  793  794  795  796  797  798  799  800  801  802  803  804  805  806  807  808  809  810  811  812  813  814  815  816  817  818  819  820  821  822  823  824  825  826   15 discharge, however all patients did have contact with at least one formal healthcare staff member. Older patients were more likely to perceive highly important network ties. Patients' spouses were significantly more likely than other network members to be highly important whilst community pharmacy staff and GP reception staff were less likely to be highly rated.
By analysing the residuals of the best fitting model it was possible to identify patients who did not have the typical range of tie values. Some of these patients described not having enough information about their medicines and needing support in organising them once home from hospital. Others lacked confidence in their efficacy and had stopped taking them.
Patients with more positive assessments of their networks described valuing the relationships they had developed over time with their care team.
In common with other studies, patients had medicines network members who were friends or family members. 17 19 Not all patients had this type of informal support, although each patient did have contact with at least one healthcare professional or healthcare support staff member. In our sample, increase in age positively impacted on the likelihood of patients perceiving their network members as highly important. Older patients have previously been found to have high expectations of their care team and to have those expectations met, 30 however older patients and their carers have also reported poor experiences of the medicines care they receive after leaving hospital, and to lack knowledge of their medicines. 4 31 This may result in older patients perceiving their care and informal support networks to be more important to them as they require more input post-discharge.
All network members were on average less likely to be highly valued by patients than GPs apart from their spouse and their specialist cardiology nurses, although the latter not significantly so. This emphasises the continued, perceived importance of patients' GPs in managing their medicines after a period in hospital, despite the reports some patients make about not being able to access GP services easily. GP receptionists and community pharmacy staff were not highly valued by the patients that came into contact with them. This contradicts evidence that patients tend to be satisfied with primary care experiences and they have confidence and trust in their healthcare teams. 32 It might also reflect views that non-clinical staff play less important roles in healthcare, However GP receptionists perform pivotal medicines management functions, 33 34 albeit not always patient-facing functions, which demand problem-solving, good judgement and a focus on patient safety.
Receptionists often need to make decisions balancing patient needs with the availability of services, which can appear as 'gatekeeping' to the patient. 33 Patients engage with pharmacy delivery drivers delivering to their homes and community pharmacy staff who may act as a proxy for contact with a community pharmacist and they may not see a pharmacist in   827  828  829  830  831  832  833  834  835  836  837  838  839  840  841  842  843  844  845  846  847  848  849  850  851  852  853  854  855  856  857  858  859  860  861  862  863  864  865  866  867  868  869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885   16 person. Because patients do not automatically have contact with a community pharmacist after their discharge and many do not see their GP, opportunities to support their medicines use may be missed.
The ego-net approach to exploring a complex system
Using the ego-net approach we were able to construct patients' networks as patients experienced them, rather than how this healthcare system was designed to be delivered.
Here, the patient was in the role of perceiver of their system in the form of ties to others concerning their medicines, rather than simply those that routinely and explicitly appear between professionals in care delivery. The networks reflect patient access of formal healthcare services and the availability of informal social support resources to access medicines. The multi-level model was able to reflect how individual patients' networks were valued differently at the individual level; and that every person's experience of healthcare is different. During the study, exploring personal interactions was invaluable in understanding how the system manifested itself to patients. The networks patients described were sets of independent actors working in parallel to meet the goal of managing medicines. 10 In our study membership of each patient-described network varied and changed according to their needs, preferences and ability to adapt following their admission to the hospital, and the availability of services and support. The systems patients described were embedded within other systems and by nature would overlap with other systems, for example one GP would treat many patients but each of those patients would have different specialist clinicians managing their medicines and different people providing informal support. These medicines management systems also co-existed and interacted with other healthcare systems, for example those that commission healthcare services, or run primary care or hospital services. 11 Moreover, patients themselves are complex, and are faced with social, economic, personal, biological, and clinical circumstances which are also variable and unpredictable and these combined forces impact on how they respond to or manage treatment and care services. 35 36 
Implications for policy
An important measure of the quality of healthcare is whether it provides care designed to meet individual patient's needs. 37 This research has demonstrated that every person's experience of medicines management is individual, however, the extent to which the care that patients experience is individualised or tailored to their needs and values is questionable. Patient-centred approaches are key to the successful optimisation of medicines. 38 It is undeniable that patients access the services of many different healthcare practitioners during this period of their recovery and in this sense they are managing one-to- many relationships with their care teams in the course of their medicines self-management.
Patients in other research have described this as burdensome, 4 and even if patients experienced individual, patient-centred encounters with a clinician, such as a cardiac rehabilitation nurse, the overall system itself may not have been calibrated to deliver patientcentred medicines management. Interventions have attempted to enhance the patientcentredness of medicines management, although few have been delivered by multidisciplinary teams. 39 Policy must address, therefore, how an integrated patient-centred medicines management process could be designed and embedded to make it an actionable goal for all care providers within healthcare economies.
The data suggest that there are inconsistencies in the support patients access to manage their medicines once they leave the hospital. Whilst this in part reflects individual variation in patients' care needs and the complexity in the system, after leaving the hospital one in four patients had no contact with a GP who may be expected to have an overview of the care patients receive from different healthcare professionals and the different treatments prescribed for different chronic conditions. The UK NICE guidance stresses how medicines optimisation should be focussed on the involvement of all HCPs and social care professionals involved in the patient's care and that professional collaboration across healthcare settings is required. 38 It is difficult to ascertain what consideration is given to patients' hospital discharge and medicines by somebody in primary care looking across patients' co-morbidities and their subsequent appointments with specialists in their different health conditions. Given that changes to medicines made by one clinician can impact on the patient's co-morbidities, consideration needs to be given to drug-condition interactions.
Policy has attempted to extend and expand the role of community pharmacists in supporting patients with their medicines and build patient knowledge of their medicines over time to complement the care they receive from their GP and reduce the demand for GP services. 40 41 In the UK patients usually receive a supply of medicines in hospital to take home and then receive a follow-up prescription from their GP, which they then would access a community with GPs, they were not important network members. Our findings suggest that community pharmacy services could be better integrated into the post-discharge pathway to support patients in using their medicines following a period in hospital, especially as their information and support needs may change after discharge. 42 In addition the increase in GP practicebased pharmacists may provide an additional resource to optimise treatment across health conditions and clinical specialisms. 43
Implications for further research
The research has expanded our understanding that informal contacts are leveraged by many patients to gain support in medicines management. Spouses in particular played highly valued roles for patients. It is accepted that people's social networks impact on their health and wellbeing, 44 45 our study has shown the informal networks surrounding patients are as important to them as more formal healthcare practitioners and that people's health and treatment is experienced through social ties, either through personal contacts supporting and facilitating recovery and access to treatment, or through the social context in which people experience socio-technical healthcare systems. There is a clear opportunity for SNA to explore and understand more about people's behaviours and experiences with their medicines. Whole network approaches can be adopted to explore healthcare systems which include patients. 46 
Limitations
This work focused on a single health condition, and although the findings from this study cannot be generalised to the broader patient population, patients with a range of different health conditions are likely to share some of the same experiences in the post-discharge management of their medicines. The necessity to conduct a relatively small sample study to determine the extent of patients' networks through face-to-face interview methods meant that the quantitative data analysis does not aim to be statistically inferential. This was a cross-sectional study that mapped patients' networks and is subject to some of the inherent biases of this approach. This approach did not allow us to take into account the temporal order of medicines management care or support patients were able to access. In theory, this data might have been available in patient diaries, however not all patients felt able to keep a diary. The networks represented patients' views of the medicines management system and this project did not attempt to corroborate their views with other sources of data such as their medical records or the views of healthcare professionals and informal carers. Patients' experiences of healthcare systems are, however, important data in determining the quality 19 and safety of care. Networks were recorded or described by patients who may not have accurately noted or recalled their medicines management interactions.
Conclusion
Patients experience medicines management as individual systems comprising healthcare staff and personal contacts and patients value system components individually. Analysing the model residuals from the quantitative analysis, and exploring patients' experiences qualitatively was a novel application of mixed methods to network data. There are opportunities to improve how medicines are managed to reflect the care and support needs of individuals so that it is person-centred. Using this ego-net approach it is possible to understand this complex healthcare system as patients experienced it, rather than how policy suggests it is delivered.
